James M. Stevenson

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2D6</i>, <i>CYP2C19</i>, <i>CYP2B6</i>, <i>SLC6A4</i>, and <i>HTR2A</i> Genotypes and Serotonin Reuptake Inhibitor Antidepressants

Chad Bousman, James M. Stevenson, Laura B. Ramsey et al. · Clinical Pharmacology & Therapeutics · 2023 · 325 citations · Full text

Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention

Larisa H. Cavallari, Craig R. Lee, Amber L. Beitelshees et al. · JACC: Cardiovascular Interventions · 2017 · 303 citations

Percutaneous Coronary Intervention, Thrombosis, Multisite Investigation +10

Binding Site Elucidation of Hydantoin-Based Antagonists of LFA-1 Using Multidisciplinary Technologies:  Evidence for the Allosteric Inhibition of a Protein−Protein Interaction

K Last-Barney, Walter Davidson, Mario Cardozo et al. · Journal of the American Chemical Society · 2001 · 130 citations

Allosteric Inhibition, Drug Target, Immunocytochemical Technique +22

Multisite Investigation of Strategies for the Implementation of <i>CYP2C19</i> Genotype‐Guided Antiplatelet Therapy

Philip E. Empey, James M. Stevenson, Sony Tuteja et al. · Clinical Pharmacology & Therapeutics · 2017 · 124 citations · Full text

Patient Selection, Pharmacotherapy, Thrombosis +17

A new measure of health-related quality of life for children: Preliminary findings

Philip Graham, James M. Stevenson, Deborah Flynn · Psychology and Health · 1997 · 82 citations

Quality Of Life, Family Medicine, Life Assessment +24